Atlas Trials

Apmonia Therapeutics

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Apmonia Therapeutics

RecordFirmDate
A First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Anti-tumour Activity of TAX2 in Patients With Relapsed/Refractory Advanced/Metastatic Solid Tumours (NCT07688148)Apmonia Therapeutics2026-10-01

Track Apmonia Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.